A re-assessment of the role of combined androgen blockade for advanced prostate cancer

被引：64

作者：

Klotz, L

Schellhammer, P

Carroll, K

机构：

[1] Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Div Urol, Toronto, ON M4N 3M5, Canada

[2] Eastern Virginia Med Sch, Norfolk, VA 23501 USA

[3] AstraZeneca, Macclesfield, Cheshire, England

来源：

BJU INTERNATIONAL | 2004年 / 93卷 / 09期

关键词：

combined androgen blockade; bicalutamide; antiandrogen; prostate cancer; advanced; castration;

D O I：

10.1111/j.1464-410X.2004.04803.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Combined androgen blockade is a controversial topic, which has arguments both for and against. It is revisited by the authors of this mini-review, with a full discussion on the benefits and cautions with this approach. A wide range of other issues is also addressed in this section: bilateral testicular cancer, male-factor infertility, and buccal mucosa urethroplasty. All of these are of interest to general urologists, as well as to those with a more specific area of interest.

引用

页码：1177 / 1182

页数：6

共 20 条

[1] *AG HLTH CAR POL R, REL EFF COST EFF MET
[2] AKAZA H, 2003, 39 ANN M AM SOC CLIN
[3] Aprikian Armen G, 2003, Can J Urol, V10, P1986
[4] A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA
CRAWFORD, ED
EISENBERGER, MA
MCLEOD, DG
SPAULDING, JT
BENSON, R
DORR, FA
BLUMENSTEIN, BA
DAVIS, MA
GOODMAN, PJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) : 419 - 424
[5] Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Culig Z.
Hoffmann J.
Erdel M.
Eder I.E.
Hobisch A.
Hittmair A.
Bartsch G.
Utermann G.
Schneider M.R.
Parczyk K.
Klocker H.
[J]. British Journal of Cancer, 1999, 81 (2) : 242 - 251
[6] Dalesio O, 2000, LANCET, V355, P1491
[7] Bilateral orchiectomy with or without flutamide for metastatic prostate cancer
Eisenberger, MA
Blumenstein, BA
Crawford, ED
Miller, G
McLeod, DG
Loehrer, PJ
Wilding, G
Sears, K
Culkin, DJ
Thompson, IM
Bueschen, AJ
Lowe, BA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) : 1036 - 1042
[8] Active-control trials:: How would a new agent compare with placebo?: A method illustrated clopidogrel, aspirin, and placebo
Fisher, LD
Gent, M
Büller, HR
[J]. AMERICAN HEART JOURNAL, 2001, 141 (01) : 26 - 32
[9] Gottlieb B, 1999, HUM MUTAT, V14, P527, DOI 10.1002/(SICI)1098-1004(199912)14:6<527::AID-HUMU12>3.0.CO
[10] 2-X

← 1 2 →